Ignite Creation Date:
2025-12-24 @ 4:19 PM
Ignite Modification Date:
2026-01-07 @ 5:31 AM
Study NCT ID:
NCT05311566
Status:
RECRUITING
Last Update Posted:
2022-04-13
First Post:
2022-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer
Sponsor:
Lei Li
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-27
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-27
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03-27
Completion Date Type:
ESTIMATED
First Submit Date:
2022-03-27
First Submit QC Date:
None
Study First Post Date:
2022-04-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-05
Last Update Post Date:
2022-04-13
Last Update Post Date Type:
ACTUAL